Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.

Autor: Lorenzen, Sylvie, Götze, Thorsten Oliver, Thuss-Patience, Peter, Biebl, Matthias, Homann, Nils, Schenk, Michael, Lindig, Udo, Heuer, Vera, Kretzschmar, Albrecht, Goekkurt, Eray, Haag, Georg Martin, Riera-Knorrenschild, Jorge, Bolling, Claus, Hofheinz, Ralf-Dieter, Zhan, Tianzuo, Angermeier, Stefan, Ettrich, Thomas Jens, Siebenhuener, Alexander Reinhard, Elshafei, Moustafa, Bechstein, Wolf Otto
Zdroj: Journal of Clinical Oncology; 2/1/2024, Vol. 42 Issue 4, p410-420, 14p
Databáze: Supplemental Index